The proposed event-driven approach for Bayesian two-stage single-arm phase II trial design is a novel clinical trial design and can be regarded as an extension of the Simon’s two-stage design with the time-to-event endpoint. This design is motivated by cancer clinical trials with immunotherapy and molecularly targeted therapy, in which time-to-event endpoint is often a desired endpoint.
| Version: | 0.1.1 |
| Published: | 2021-05-04 |
| DOI: | 10.32614/CRAN.package.BayesDesign |
| Author: | Chia-Wei Hsu [aut, cre], Haitao Pan [aut], Jianrong Wu [aut] |
| Maintainer: | Chia-Wei Hsu <Chia-Wei.Hsu at stjude.org> |
| License: | GPL-2 |
| NeedsCompilation: | no |
| CRAN checks: | BayesDesign results |
| Reference manual: | BayesDesign.pdf |
| Package source: | BayesDesign_0.1.1.tar.gz |
| Windows binaries: | r-devel: BayesDesign_0.1.1.zip, r-release: BayesDesign_0.1.1.zip, r-oldrel: BayesDesign_0.1.1.zip |
| macOS binaries: | r-devel (arm64): BayesDesign_0.1.1.tgz, r-release (arm64): BayesDesign_0.1.1.tgz, r-oldrel (arm64): BayesDesign_0.1.1.tgz, r-devel (x86_64): BayesDesign_0.1.1.tgz, r-release (x86_64): BayesDesign_0.1.1.tgz, r-oldrel (x86_64): BayesDesign_0.1.1.tgz |
Please use the canonical form https://CRAN.R-project.org/package=BayesDesign to link to this page.